Effects of corticotropin-releasing hormone on ACTH, cortisol and 13,14-dihydro-15-keto prostaglandin E2 in patients with diabetes insipidus before and after captopril treatment

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 6, 1996, Pages 433-437

  Zacharieva, Sabina ^a   Andreeva, Maria ^a   Orbetzova, Maria ^a   Wippermann, Marieluise ^b   Mucha, Istvan ^c   Andonova, Katia ^a   Sheitanova, Stanka ^d  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Nichols Institute of Diagnostics   (Switzerland)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d MILITARY MEDICAL ACADEMY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN E2; CAPTOPRIL;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; DIABETES INSIPIDUS; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; URINE OSMOLALITY; URINE VOLUME;

EID: 0029787310     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90027-7     Document Type: Article

References (38)

1. Rivier C. L., Plotzky P. M. Mediation by corticotropin releasing factor (CRF) of adenohypophyseal hormone secretion. Ann Rev Physiol 1986; 48: 475-494.
2. Milson S. R., Conglen J. V., Donald R. A., Espiner E. A., Nicholls M. G., Livesey J. H. Augmentation of the response to CRF in man: Relative contribution of endogenous angiotensin and vasopressin. Clin Endocrinol 1985; 22: 623-628.
3. Lin J. H., Muse K., Contreras P. et al. Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor by vasopressin in women. J Clin Endocrinol Metab 1983; 57: 1087-1089.
4. Lamberts S. W. J., Verleun T., Oosterom R., De Long F., Hackeng W. H. L. Corticotropin releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 1984; 58: 298-309.
5. De Bold C. R., Sheldon W. R., De Cherney G. S. et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin releasing factor. J Clin Invest 1984; 73: 533-538.
6. Bahr R., Hensen J., Hader O., Oelkers W. Effects of osmotically stimulated endogenous vasopressin in basal and CRH-stimulated ACTH release in man. Acta Endocrinol 1988; 117: 103-108.
7. Watabe T., Tanaka T., Kumagae K. et al. Role of endogenous arginine vasopressin in potentiating CRH-stimulated corticotropin secretion in man. J Clin Endocrinol Metab 1988; 66: 1132-1137.
8. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. New Engl J Med 1989; 321: 492-496.
9. Wakui H., Nishinari T., Nishimura S., Endo Y., Nakamoto Y., Miura A. B. Case report: Inappropriate secretion of antidiuretic hormone in isolated adrenocorticotropin deficiency. Am J Med Sci 1991; 301: 319-321.
10. Sobel D. O. Characterization of angiotensin-mediated ACTH release. Neuroendocrinology 1983; 36: 249-253.
11. Rivier C., Vale W. Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor. Regul Pept 1983; 7: 253-258.
12. Gaillard R. C., Favrod-Coune C. A., Capponi A. M., Muller A. F. Corticotropin releasing activities of the renin-angiotensin system peptides in rat and in man. Neuroendocrinology 1985; 41: 511-517
13. Zacharieva S., Matrozov P., Stoeva I., Andonova K. The effect of angiotensin-converting enzyme inhibition on ACTH response to corticotropin releasing hormone (CRH) in normal men. Horm Metab Res 1991; 23: 245-246.
14. 2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers. Arch Pharmacol 1986; 333: 149-154.
15. Bernardini R., Chiarenza A., Calogero A. E., Gold P. W., Chrousos G. P. Arachidonic acid metabolites mediate rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 1989; 50: 708-715.
16. Gerozissis K., Saavedra J. M., Dray F. Prostanoid profile in specific brain areas, pituitary and pineal gland of the male rat. Influence of experimental condition. Brain Res 1983; 279: 133-139.
17. 2 to rat brain membranes and synaptosomes. Brain Res 1982; 236: 227-233.
18. Abou-Samra A.-B., Catt K. J. Role of arachidonic acid in the regulation of adrenocorticotropin release from rat anterior pituitary cell cultures. Endocrinology 1986; 119: 1427-1431.
19. Samuelsson B., Granström E., Gréen K., Hamberg M., Hammarström S. Prostaglandins. Ann Rev Biochem 1975; 44: 669-695.
20. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980; 20: 947-957
21. 2. Prostaglandins 1980; 19: 917-922.
22. Kjoer A., Knigge U., Bach F. W., Warberg J. Impaired histamine-induced and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Bratellboro rats. Neuroendocrinology 1993; 57: 1035-1041.
23. Schuermeyer T. H., Chrousos G. P., Avgerinos P. C., Gold P. W., Cutler G. B., Loriaux D. L. Corticotropin releasing factor has full activity in patients with diabetes insipidus. Clin Res 1984; 32: 272A
24. Mazza E., Goffi S., Barchi P. et al. Enhanced adrenocorticotrophic hormone and cortisol responses to corticotropin-releasing hormone in central idiopathic diabetes insipidus. Eur J Endocrinol 1994; 130: 121-124.
25. Spinedi E., Negro-Vilar A. Angiotensin II increases ACTH release in the absence of endogenous arginin-vasopressin. Life Sci 1984; 34: 721-729.
26. Zusman R. M., Keiser H. R., Handler J. S. Vasopressin stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect on water flow. J Clin Invest 1977; 60: 1339-1347.
27. Zusman R. M., Keiser H. R., Handler J. S. Effect of adrenal steroids on vasopressin stimulated PGE synthesis and water flow. Am J Physiol 1978; 234: F532-F540.
28. Walker L. A., Whorton A. R., Smigel M., France R., Frölich J. C. Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol 1978; 235: F180-F185.
29. Dunn M. J., Kinter L. B., Beeuwkes III R., Shier D, Greeley H. P., Valtin H. Interaction of vasopressin and renal prostaglandins in the homozygous diabetes insipidus rat. Adv Prostaglandin Thromboxane Res 1980; 7: 1009-1015.
30. Bankir L., Trainh Trang Tan M.-M., Nivez M.-R, Sraer J., Ardaillou R. Altered PG production by glomeruli and papilla of rats with hereditary diabetes insipidus. Prostaglandins 1980; 20: 349-365.
31. Fichman M., Zia P., Zipser R. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus. Adv Prostaglandin Thromboxane Res 1980; 7: 1193-1197.
32. 2 responses to AVP and DDAVP in subjects with central and nephrogenic diabetes insipidus. Am J Physiol 1985; 248: 354-359.
33. Hober C., Vantyghem M.-C., Racadot A., Cappoen J.-P., Lefebvre J. Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (Indomethacin). Horm Res 1992; 37: 190-195.
34. Düsing R., Herrmann R., Glänzer K., Vetter H., Overlack A., Kramer H.-J. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus. Clin Sci 1981; 61: 61-67.
35. Kaye Z., Zipser R., Hahn J., Zia P., Horton R. Water diuresis is a major regulator of prostaglandin E excretion in man. Adv Prostaglandin Thromboxane Res 1980; 7: 1017-1019.
36. Koev D., Zacharieva S., Andonova K. Involvement of prostaglandins in the action of captopril in type II diabetic patients. Exp Clin Endocrinol 1989; 93: 11-18.
37. 2 in normal subjects. Prostaglandins Leukot Essent Fatty Acids 1995 (in press).
38. Nussey S. S., Page S. R., Peterson D. B. et al. Corticotropin releasing hormone (CRH 1-41) stimulates the secretion of adrenocorticotropin, vasopressin and oxytocin but not adrenocorticotropin precursors: evidence from petrosal sinus sampling in man. Clin Endocrinol 1991; 34: 51-56.